Echo-enhanced ultrasound for diagnosis and management in stroke patients

European Journal of Ultrasound

Volumn 7, Issue SUPPL. 3, 1998, Pages

  Ringelstein, E Bernd ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Cerebrovascular disease; Contrast media; Echo enhancing agent; Ischemic stroke; Transient ischemic attacks; Ultrasound

Indexed keywords

ALBUNEX; CONTRAST MEDIUM; ECHOVIST; GADOLINIUM PENTETATE; IOPROMIDE; SHU 508;

CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DOPPLER ECHOGRAPHY; HUMAN; INJECTION SITE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SIGNAL NOISE RATIO; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STROKE; TASTE DISORDER; TRANSIENT ISCHEMIC ATTACK; ULTRASOUND;

EID: 0031818046     PISSN: 09298266     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-8266(98)00027-5     Document Type: Article

References (57)

1. Aaslid R, Markwalder TM, Nornes H. Noninvasive transcranial Doppier ultrasound recording of flow velocity in basal cerebral arteries. J Neurosurg 1982;57:769-74.
2. Arnolds BJ, von Reutern G-M. Transcranial dopplersonography. Examination technique and normal reference values. Ultrasound Med Biol 1986;12(2):115-23.
3. Balen FG, Allen CM, Lees WR. Ultrasound contrast agents. Clin Radiol 1994;49(2):77-82.
4. Barnhart JL, Harada M, Lyle LR, Saravis CA. Immunological reactions of human recipients to repeated exposures to Albunex microspheres. Invest Radiol 1991;26:S192-3.
5. Becker G, Lindner A, Bogdahn U. Imaging of the vertebrobasilar system by transcranial color-coded real-time sonography. J Ultrasound Med 1993a;12:395-401.
6. Becker G, Lindner A, Winkler J, Hoffmann E, Bogdahn U. Differentiation between ischemic and hemorrhagic stroke by transcranial color-coded real-time sonography. J Neuroimaging 1993b;3:41-7.
7. Becker G, Bogdahn U, Gehlberg C, Frohlich T, Hofman E, Schlief R. Transcranial color-coded real-time sonography of the intracranial veins. J Neuroimaging 1995;5(2):87-94.
8. Becker G, Lindiner A, Hoffmann E, Bogdahan U. Contribution of transcrannial color-coded real-time sonography to the etiopathogenetic classification of the middle cerebral stenosis. J Clin Ultrasound 1994;22:471-7.
9. Bogdahn U, Becker G. Transcranial color Doppler imaging. In: Tegeler CH, Babikian VL, Gomes CR, editors. Neurosonology. St. Louis, Boston: Mosby, 1996:214-20.
10. Bogdahn U, Becker G, Frohlich T. Contrast enhanced colour coded real-time sonography of cerebrovascular disease. Echocardiography 1993a;10:678 abstract.
11. Bogdahn U, Becker G, Schlief R, Reddig J, Hassel W. Contrast-enhanced transcranial color-coded real-time sonography. Results of a Phase-two study. Stroke 1993b;24(5):676-84.
12. Büdingen HJ, Staudacher T. Die identifizierung der arteria baliaris mit der transkraniellen Doppler-sonographie. Ultraschall 1987;8:95-101.
13. Burns PN. Potential advantages of harmonic imaging. Adv Echocontrast 1994;4(1):17-9.
14. Burns PN. Harmonic imaging with ultrasound contrast agents. Clin Radiol 1996;51(suppl 1):50-5.
15. ® program for automated analysis of event related cerebral blood flow. J Neurosci Methods 1997;75:147-54.
16. Dorr JM. Echoenhancers in transcranial imaging: a brief update. Adv Echocontrast 1994;4:2-4.
17. Enzmann DR, Britt RH, Loyons BE, et al. Natural history of experimental intracerebral hemorrhage: sonography, computed tomography and neuropathology. Am J Neuroradiol 1981;2:517-26.
18. European Ad Hoc Consensus Group. European strategies for early intervention instroke. A report of an ad hoc consensus group meeting. Cerebrovasc Dis 1996;6:315-24.
19. European Carotid Surgery Trialist's Collaborative Group. MRC European Surgery Trial. Interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet 1991;337:1235-43.
20. Feinstein SB, Cheirif J, Ten Cate FJ, Silverman PR, Heidenreich PA, Dick C, Desir RM, Armstrong WF, Quinones MA, Shah PM. Safety and efficacy of a new transpulmonary ultrasound contrast agent: initial multicentre clinical results. J Am Coll Cardiol 1990;16:316-24.
21. Fritzsch T, Schlief R. Levovist. Drugs Future 1995;20(12):1224-7.
22. Gorelick PB. Stroke prevention. An opportunity for efficient utilization of health care resources during the coming decade. Stroke 1994;25(1):220-4.
23. Gramiak R, Shah PM. Echocardiography of the aortic root. Invest Radiol 1968;3:356-66.
24. Hajduczki I, Rajagopalam RE, Meerbaum S, et al. Effects of intracoronary administered echo-contrast agents on epicardial coronary flow, ECG and global and regional hemodynamics. J Cardiovasc Ultrason 1987;6:85-93.
25. Hassler W, Burger R. Arteriovenous malformations. In: Newell DW, Aaslid R, editors. Transcranial Doppler. New York: Raven Press, 1992:123-5.
26. Itoh T, Matsumoto M, Handa N, Maeda H, Hougaku H, Hashimoto H, Etani H, Tsukamoto Y, Kamada T. Rate of successful recording of blood flow signals in the middle cerebral artery using transcranial Doppler sonography. Stroke 1993;24(8):1192-5.
27. Jørgensen HS, Nakayama H, Reith J, et al. Factors delaying hospital admission in acute stroke. The Copenhagen stroke study. Cerebrovasc Dis 1996;6(suppl 2): 130 abstract.
28. Ley Pozo J, Ringelstein EB. Noninvasive detection of occlusive disease of the carotid siphon and middle cerebral artery. Ann Neurol 1990;28:640-7.
29. Masdeu JC, Brass LM. SPECT imaging of stroke. J Neuroimaging 1995;5(suppl 1):S14-22.
30. Mattrey RF, Steinbach GC. Ultrasound contrast agents; state of the art. Invest Radiol 1991;26:S5-S11.
31. Mohr JP, Caplan LR, Melski JE, et al. The Harvard cooperative stroke register: a prospective register. Neurology 1978;28:754-62.
32. Nanda NC. Echocontrast enhancers, how safe are they? In: Nanda N, Schlief R, editors. Advances in Echo imaging using contrast enhancement. Dordrecht: Kluwer, 1993:97-110.
33. Newell DW. Trauma and brain death. In: Tegeler CH, Babikian VL, Gomes CR, editors. Neurosonology. St. Louis, Boston: Mosby, 1996:189-99.
34. North American Symptomatic Carotid Endarterectomy Trial. (NASCET). Methods, patient characteristics and progress. Stroke 1991;6:711-20.
35. Otis SM, Ringelstein EB. Transcranial Doppler sonography. In: Zweibel WJ, editor. Introduction to Vascular Ultrasonography. Philadelphia, PA: Saunders, 1992:145-71.
36. Otis S, Rush M, Boyajian R. Contrast-enhanced transcranial imaging. Results of an American phase-two study. Stroke 1995;26(2):203-9.
37. Ramadan NM, Deveshwar R, Levine SR. Magnetic resonance and clinical cerebrovascular disease, an update. Curr Concepts Cerebrovasc Dis Stroke 1989;24:13-8.
38. Ries F. Clinical experience with echo-enhanced transcranial Doppler and Duplex imaging. J Neuroimaging 1997;7(suppl 1):S15-21.
39. Ries F, Honisch C, Lambertz M, Schlief R. A transpulmonary contrast medium enhances the transcranial Doppler signal in humans. Stroke 1993;24(12):1903-9.
40. Ringelstein EB. Cerebrovascular diseases. In: Tegeler Ch H, Babikian VL, Gomes CR, editors. Neurosonology. St. Louis, Baltimore: Mosby, 1996:172-88.
41. Ringelstein EB, Otis SM. Physiological testing of vasomotor reserve. In: Newell DW, Aaslid R, editors. Transcranial Doppler. New York: Raven Press, 1992:83-99.
42. 2-induced cerebral vasomotor response in individuals and patients with internal carotid artery occlusions. Stroke 1988;19:963-9.
43. Ringelstein EB, Kahischeuer B, Niggemeyer E, Otis SM. Transcranial Doppler sonography: anatomical landmarks and normal velocity values. Ultrasound Med Biol 1990;8:745-61.
44. Ringelstein EB, Weiller C, Weckesser M, Weckesser S. Cerebral vasomotor reactivity is significantly reduced in low-flow as compared to thromboembolic infarctions: the key role of the circle of Willis. J Neurol Sci 1994;121:103-9.
45. Rosenkranz K, Langer R, Cordes M, Felix R. Transkranielle Doppler-sonographie bei zerebrovascuiren Erkrankungen. ROFO Fortschr Geb Rongenstr Neuen Bildgeb Verfahr 1991;155:72-9.
46. Rosenkranz K, Zendel W, Langer R, Heim T, Schubeus P, Scholz A, Schlief R, Schurmann R, Felix R. Contrast-enhanced transcranial Doppler US with a new transpulmonary echo contrast agent based on saccharide microparticles. Radiology 1993;187:439-43.
47. Russell D. The detection of cerebral emboli using Doppler ultrasound. Theoretical, experimental and clinical aspects. In: Newell DW, Aaslid R, editors. Transcranial Doppler. New York: Raven Press, 1992:207-13.
48. Schneider PA, Rossman ME, Bernstein EF, Torem S, Ringelstein EB, Otis SM. Effect of internal carotid artery occlusion on intracranial hemodynamics. Stroke 1988;19:589-93.
49. Schurmann R, Schleif R. Saccharide-based contrast agents. Characteristics and diagnostic potential. Radiol Med (Torino) 1994;87(5, suppl 1):15-23.
50. Schwarz KQ, Bezante GP, Becher H, et al. Efficacy of SH U 508 A (Levovist) as a blood pool enhancer in the Doppler evaluation of multiple vascular regions. Radiol Med (Torino) 1994;87(5, suppl 1):3-14.
51. Seiler RW, Newell DW. Subarachnois hemorrhage and vasospasm. In: Newell DW, Aaslid R, editors. Transcranial Doppler. New York: Raven Press, 1992:101-7.
52. Shanda R, Shan DJ, Bales G, Elkadi T, Yau KK, Gharib M. Persistence of Albunex ultrasound contrast agent: in vitro study of the effects of pressure and acoustic power on particle size and duration of contrast and Doppler enhancement. Circulation 1990;82(suppl III):372 abstract.
53. Shapiro JR, Reisner SA, Lichtenberg GS, et al. Intravenous contrast echocardiography with the use of sonicated albumin in humans. Systolic disappearance of left ventricular contrast after transpulmonary transmission. J Am Coll Cardiol 1990;16:1603-7.
54. Shapiro JR, Reisner SA, Meltzer RS. Clinical uses of contrast agents. In: Nanda N, Schlief R, editors. Advances in Echo Imaging using Contrast Enhancement. Dordrecht: Kluwer, 1993:135-45.
55. Shriver ME, Prockop LD. The economic approach to the stroke work-up. Curr Opin Neurol Neurosurg 1993;6(1):74-7.
56. Weiller C, Ringelstein EB, Reiche W, Thron A, Buell U. The large striatocapsular infacrt. A clinical and pathophysiological entity. Arch Neurol 1990;47:1085-91.
57. Wieneck JG, Aronson S, Walker R, et al. In vitro and in vivo stability of Albunex contrast agent. J Am Coll Cardiol 1992;19:175A.